EU IVD Regulation: A New Scrutiny System For Diagnostics

This article was originally published in The Gray Sheet

21 Jun 2016
News

Amanda Maxwell @MedtechAmanda amanda.maxwell@informa.com

Executive Summary

A European Union-centralized scrutiny system will be put into place for high-risk products under a new EU regulation for in vitro diagnostics that is heading toward adoption in the coming months.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Industries
Medical Device
Regions
Europe
Subjects
Regulation

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device Europe Regulation

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT038345

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT038345

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

EU IVD Regulation: A New Scrutiny System For Diagnostics

News

Executive Summary

Related Content

New World Of Regulation Awaits IVD Companies In Europe From Coming Reforms

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert